NP / PA
E & G Heathcare, N.P. in Family Health P.L.L.C.
E & G Heathcare, N.P. in Family Health P.L.L.C. was paid $1.78M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoE & G HEATHCARE, N.P. IN FAMILY HEALTH P.L.L.C.
STATEN ISLAND, NY 10314
STATEN ISLAND, NY 10314
33aNPI1265841894assigned 08/07/2014
33bProvider typeFamily Nurse Practitioner
28Total paid$1.78M
24GClaims127,118
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in New York
Rank by total paid#5 of 1,582
Median peer was paid$2K
This provider vs. median777×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,053 | $180K | |
| 2019 | 9,513 | $169K | |
| 2020 | 10,977 | $224K | |
| 2021 | 25,536 | $323K | |
| 2022 | 21,575 | $296K | |
| 2023 | 27,486 | $340K | |
| 2024incomplete | 24,978 | $251K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 12,316 | 11,070 | $796K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 3,944 | 3,592 | $357K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 8.7% | 1,769 | 1,751 | $155K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.6% | 1,096 | 1,091 | $100K |
| 96127 | 2.8% | 15,395 | 13,738 | $50K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.1% | 1,822 | 1,795 | $38K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.0% | 408 | 407 | $35K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.9% | 349 | 346 | $34K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 767 | 704 | $32K |
| 99385 | 1.6% | 317 | 316 | $29K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 594 | 547 | $24K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 3,140 | 2,627 | $16K |
44 more codes
| H0049 | Alcohol and/or drug screening | <1% | 3,651 | $16K |
| 96160 | <1% | 9,249 | $15K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 952 | $13K |
| 90686 | <1% | 1,080 | $12K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,604 | $9K |
| 99051 | <1% | 2,039 | $8K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,804 | $8K |
| 99406 | <1% | 756 | $6K | |
| 99173 | <1% | 2,155 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 63 | $5K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 10,495 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 689 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 139 | $3K |
| 86769 | <1% | 83 | $2K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 185 | $2K |
| 90656 | <1% | 79 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 558 | $1K |
| 90674 | <1% | 38 | $1K | |
| 90651 | <1% | 51 | $910.74 | |
| 95117 | <1% | 75 | $687.11 | |
| 87081 | <1% | 230 | $573.47 | |
| 99408 | <1% | 438 | $565.16 | |
| 81025 | <1% | 122 | $348.79 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 21 | $309.16 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 14 | $240.63 |
| 90715 | <1% | 13 | $111.50 | |
| 86580 | <1% | 15 | $101.72 | |
| 81002 | <1% | 65 | $90.04 | |
| 82270 | <1% | 38 | $83.06 | |
| 3079F | <1% | 25 | $64.24 | |
| 3078F | <1% | 14 | $20.00 | |
| 4124F | <1% | 453 | $14.88 | |
| 90461 | <1% | 13 | $13.55 | |
| 3074F | <1% | 12 | $4.24 | |
| G9920 | Screening performed and negative | 0% | 4,509 | $0.00 |
| 99072 | 0% | 1,708 | $0.00 | |
| 3725F | 0% | 11,934 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 1,488 | $0.00 |
| 90734 | 0% | 19 | $0.00 | |
| 1000F | 0% | 10,009 | $0.00 | |
| 1220F | 0% | 5,782 | $0.00 | |
| 4293F | 0% | 3,508 | $0.00 | |
| 90619 | 0% | 14 | $0.00 | |
| 94760 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHALEVI, EFRAT (FNP)